Add Yahoo as a preferred source to see more of our stories on Google. Men interviewed by CBC/Radio Canada during a six-month investigation of the hair loss drug finasteride say it caused sexual, ...

The Food and Drug Administration (FDA) issued a public warning about compounded topical versions of a popular hair loss drug sold through telehealth platforms. However, the agency has not approved any ...

The Food and Drug Administration on Tuesday posted a warning about generic forms of a popular hair-loss medication often sold by major telehealth companies including Hims, Keeps and Ro, citing reports ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA is warning about a topical spray version of finasteride, a drug often sold online by telehealth companies. Adobe ...

File on 4 Investigates whether the risks associated with the popular hair loss drug Finasteride are understood, after a 2024 review by UK drug safety regulator the MHRA prompted b ...

Noticing a receding hairline? You’re not alone — and thanks to years of research, effective treatments are within reach. Male ...

CLEVELAND, April 03, 2025 (GLOBE NEWSWIRE) -- The hair loss industry is at a tipping point. A recent Wall Street Journal exposé has reignited concerns about the severe and long-term side effects of ...

European regulators are considering withdrawing market authorizations for certain hair loss and enlarged prostate treatments, including Organon’s (NYSE:OGN) Propecia, over concerns they can trigger ...

Please provide your email address to receive an email when new articles are posted on . FDA warned of potential serious risks when using compounded topical finasteride. There are no FDA-approved ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Kate Linebaugh: My colleague, Rolfe Winkler, has a full head of hair, still he ...